Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
USB
|
James B Kelligrew
Vice Chair |
BUY
Open market or private purchase
|
Indirect | 10 Added 0.0% |
$290
$29.04 p/Share
|
Mar 28
2017 |
USB
|
James B Kelligrew
Vice Chair |
BUY
Open market or private purchase
|
Indirect | 6 Added 0.0% |
$155
$25.88 p/Share
|
Mar 28
2017 |
USB
|
James B Kelligrew
Vice Chair |
BUY
Open market or private purchase
|
Indirect | 55 Added 0.0% |
$2,902
$52.77 p/Share
|
Mar 28
2017 |
USB
|
James B Kelligrew
Vice Chair |
BUY
Open market or private purchase
|
Indirect | 8 Added 0.0% |
$184
$23.06 p/Share
|
Mar 28
2017 |
ORCL
|
Safra Catz
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 46,767 Reduced 9.19% |
$2,104,983
$45.01 p/Share
|
Mar 28
2017 |
CMCSA
|
Arthur R Block
EVP, GC and Secretary |
SELL
Open market or private sale
|
Direct | 4,044 Reduced 5.91% |
$149,426
$36.95 p/Share
|
Mar 28
2017 |
BMY
|
Lamberto Andreotti
Director |
SELL
Open market or private sale
|
Direct | 17,000 Reduced 1.72% |
$955,400
$56.2 p/Share
|
Mar 28
2017 |
SQ
|
Sarah Friar
Chief Financial Officer |
SELL
Open market or private sale
|
Indirect | 19,200 Reduced 16.67% |
$329,280
$17.15 p/Share
|
Mar 28
2017 |
RETA
|
Abb Vie Inc.
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 450,000 Reduced 27.43% |
$10,125,000
$22.5 p/Share
|
Mar 28
2017 |
INTU
|
Henry Tayloe Stansbury
EVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 1,871 Reduced 69.07% |
$222,181
$118.75 p/Share
|
Mar 28
2017 |
CMCSA
|
Arthur R Block
EVP, GC and Secretary |
SELL
Open market or private sale
|
Direct | 15,846 Reduced 16.31% |
$589,154
$37.18 p/Share
|
Mar 27
2017 |
BMY
|
Lamberto Andreotti
Director |
SELL
Open market or private sale
|
Direct | 17,000 Reduced 1.69% |
$954,380
$56.14 p/Share
|
Mar 27
2017 |
TMUS
|
Thomas Christopher Keys
Pres. MetroPCS |
SELL
Open market or private sale
|
Direct | 81,400 Reduced 18.69% |
$5,235,648
$64.32 p/Share
|
Mar 24
2017 |
ADI
|
Vincent Roche
Chair & CEO |
SELL
Open market or private sale
|
Direct | 47,400 Reduced 62.8% |
$3,877,320
$81.8 p/Share
|
Mar 24
2017 |
COST
|
James D Sinegal
Director |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 6.52% |
$8,317,500
$166.35 p/Share
|
Mar 24
2017 |
COST
|
James D Sinegal
Director |
SELL
Open market or private sale
|
Indirect | 50,000 Reduced 7.49% |
$8,317,500
$166.35 p/Share
|
Mar 24
2017 |
ORCL
|
Safra Catz
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 518,072 Reduced 52.87% |
$23,323,602
$45.02 p/Share
|
Mar 24
2017 |
CMCSA
|
Arthur R Block
EVP, GC and Secretary |
SELL
Open market or private sale
|
Direct | 10,215 Reduced 14.85% |
$380,407
$37.24 p/Share
|
Mar 24
2017 |
NKE
|
Eric D Sprunk
CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 16.66% |
$2,783,500
$55.67 p/Share
|
Mar 24
2017 |
NKE
|
John C Lechleiter
Director |
BUY
Open market or private purchase
|
Direct | 1,000 Added 3.37% |
$56,300
$56.3 p/Share
|
Mar 24
2017 |
VC
|
Robert Manzo
Director |
BUY
Open market or private purchase
|
Indirect | 2,000 Added 24.18% |
$191,400
$95.7 p/Share
|
Mar 24
2017 |
USB
|
James B Kelligrew
Vice Chair |
BUY
Open market or private purchase
|
Indirect | 3 Added 0.0% |
$157
$52.64 p/Share
|
Mar 24
2017 |
CMCSA
|
Arthur R Block
EVP, GC and Secretary |
SELL
Open market or private sale
|
Direct | 12,303 Reduced 12.22% |
$455,211
$37.0 p/Share
|
Mar 23
2017 |
MYL
|
Laboratories Abbott
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 44,000,000 Reduced 63.08% |
$1,830,399,933
$41.6 p/Share
|
Mar 23
2017 |
ORCL
|
Safra Catz
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 819,829 Reduced 63.96% |
$36,908,702
$45.02 p/Share
|
Mar 23
2017 |
TMUS
|
Thomas Christopher Keys
Pres. MetroPCS |
SELL
Open market or private sale
|
Direct | 18,600 Reduced 4.99% |
$1,181,472
$63.52 p/Share
|
Mar 23
2017 |
AMT
|
Edmund Di Santo |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 9.56% |
$1,788,450
$119.23 p/Share
|
Mar 23
2017 |
PLNT
|
Christopher Rondeau |
SELL
Open market or private sale
|
Indirect | 20,000 Reduced 100.0% |
$394,600
$19.73 p/Share
|
Mar 23
2017 |
FDX
|
Michael L Ducker
President & CEO/FedEx Freight |
SELL
Open market or private sale
|
Direct | 12,899 Reduced 20.59% |
$2,500,858
$193.88 p/Share
|
Mar 23
2017 |
FDX
|
Shirley A Jackson
Director |
SELL
Open market or private sale
|
Direct | 6,145 Reduced 43.1% |
$1,186,722
$193.12 p/Share
|
Mar 23
2017 |
FDX
|
Alan B Graf Jr
EVP CHIEF FINANCIAL OFF |
SELL
Open market or private sale
|
Direct | 25,655 Reduced 14.55% |
$5,002,725
$195.0 p/Share
|
Mar 23
2017 |
HOFD
|
Jefferies Financial Group Inc. |
BUY
Open market or private purchase
|
Direct | 783,889 Added 6.74% |
$31,316,366
$39.95 p/Share
|
Mar 23
2017 |
MCD
|
John J Mulligan |
BUY
Open market or private purchase
|
Direct | 1,600 Added 50.0% |
$206,304
$128.94 p/Share
|
Mar 22
2017 |
SEIC
|
Joseph P Ujobai
EXECUTIVE VICE PRESIDENT |
SELL
Open market or private sale
|
Direct | 17,085 Reduced 57.67% |
$1,292,309
$75.64 p/Share
|
Mar 22
2017 |
ORCL
|
Dorian Daley
EVP and General Counsel |
SELL
Open market or private sale
|
Direct | 100,000 Reduced 76.35% |
$4,484,000
$44.84 p/Share
|
Mar 22
2017 |
TRU
|
Advent International Corp
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 992,500 Reduced 3.58% |
$36,295,725
$36.57 p/Share
|
Mar 22
2017 |
TRU
|
Advent International Corp
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 992,500 Reduced 3.58% |
$36,295,725
$36.57 p/Share
|
Mar 22
2017 |
TRU
|
Christopher Egan
Director |
SELL
Open market or private sale
|
Indirect | 16,674 Reduced 3.58% |
$609,768
$36.57 p/Share
|
Mar 22
2017 |
TRU
|
Steven M Tadler
Director |
SELL
Open market or private sale
|
Indirect | 16,079 Reduced 3.58% |
$588,009
$36.57 p/Share
|
Mar 22
2017 |
PLNT
|
Christopher Rondeau |
SELL
Open market or private sale
|
Indirect | 20,000 Reduced 100.0% |
$394,600
$19.73 p/Share
|
Mar 22
2017 |
ORCL
|
Safra Catz
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 109,572 Reduced 19.17% |
$4,944,984
$45.13 p/Share
|
Mar 22
2017 |
TRU
|
Gscp Vi Advisors, L.L.C. |
SELL
Open market or private sale
|
Indirect | 992,500 Reduced 2.17% |
$36,295,725
$36.57 p/Share
|
Mar 22
2017 |
TRU
|
Goldman Sachs Group Inc |
SELL
Open market or private sale
|
Indirect | 992,500 Reduced 2.17% |
$36,295,725
$36.57 p/Share
|
Mar 22
2017 |
TRU
|
Sumit Rajpal |
SELL
Open market or private sale
|
Indirect | 992,500 Reduced 2.17% |
$36,295,725
$36.57 p/Share
|
Mar 22
2017 |
CMCSA
|
Arthur R Block
EVP, GC and Secretary |
SELL
Open market or private sale
|
Direct | 8,269 Reduced 9.39% |
$307,111
$37.14 p/Share
|
Mar 22
2017 |
ADBE
|
Ann Lewnes
EVP, CMO, Corp Strategy & Dev |
SELL
Open market or private sale
|
Direct | 2,233 Reduced 3.15% |
$279,125
$125.0 p/Share
|
Mar 22
2017 |
SQ
|
James Morgan Mc Kelvey Jr.
Director |
SELL
Open market or private sale
|
Direct | 55 Reduced 0.06% |
$950
$17.27 p/Share
|
Mar 21
2017 |
CMCSA
|
Arthur R Block
EVP, GC and Secretary |
SELL
Open market or private sale
|
Direct | 7,053 Reduced 7.93% |
$264,346
$37.48 p/Share
|
Mar 21
2017 |
ORCL
|
Safra Catz
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 3,000,000 Reduced 86.66% |
$134,970,005
$44.99 p/Share
|
Mar 21
2017 |
CVS
|
Troyen A Brennan
EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 23,849 Reduced 25.29% |
$1,877,632
$78.73 p/Share
|
Mar 21
2017 |